AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,219,581 | -13.0% | 17,450 | -23.2% | 0.03% | -20.5% |
| Q1 2023 | $1,402,110 | -24.1% | 22,732 | -5.1% | 0.04% | -25.0% |
| Q4 2022 | $1,847,649 | +475.6% | 23,955 | +181.6% | 0.05% | +160.0% |
| Q4 2021 | $321,000 | +49.3% | 8,508 | +30.6% | 0.02% | +17.6% |
| Q3 2021 | $215,000 | -74.1% | 6,515 | -35.5% | 0.02% | -70.7% |
| Q2 2020 | $831,000 | -51.5% | 10,102 | -65.3% | 0.06% | -53.2% |
| Q1 2020 | $1,713,000 | +616.7% | 29,120 | +1160.1% | 0.12% | +785.7% |
| Q4 2019 | $239,000 | -30.7% | 2,311 | -86.5% | 0.01% | -53.3% |
| Q3 2019 | $345,000 | +169.5% | 17,069 | -25.5% | 0.03% | +114.3% |
| Q4 2017 | $128,000 | – | 22,911 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |